Pilot Study of Sodium Nitrite in Resuscitated Cardiac Arrest Patients
Phase 1 Hospital Based Study of Sodium Nitrite in Resuscitated Cardiac Arrest Patients
1 other identifier
interventional
11
1 country
1
Brief Summary
Despite advances in cardiac arrest resuscitation survival from cardiac arrest is less than 20-30% and new therapies are urgently needed. Sodium nitrite infused during resuscitation from cardiac arrest has recently been shown to improve survival in a mouse model of cardiac arrest and our group is eager to test this hypothesis in a clinical trial. Our overall hypothesis is that an infusion of 2 μmole/kg sodium nitrite during resuscitation will increase the proportion of patients who will survive cardiac arrest. In preparation for a clinical trial, preliminary safety and efficacy data (phase 1) is needed which is the primary goal of this study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Started Jan 2010
Longer than P75 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 6, 2010
CompletedFirst Posted
Study publicly available on registry
August 10, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2016
CompletedMay 18, 2017
May 1, 2017
6.3 years
August 6, 2010
May 16, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Blood pressure
2 hour
nitrite concentration levels in blood
2 hour
Interventions
Eligibility Criteria
You may qualify if:
- Successfully resuscitated from cardiac arrest by paramedics in the field Age 18 or older Comatose IV access
You may not qualify if:
- traumatic cause of cardiac arrest known DNAR Patient requiring vasopressors at time of randomization SBP \<105 PaO2 of less than 90% on FiO2 of 1.0
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Washingtonlead
- Medic One Foundationcollaborator
Study Sites (1)
Harborview Medical Center
Seattle, Washington, 98104, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Francis Kim, MD
University of Washington
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Medicine/Division of Cardiology
Study Record Dates
First Submitted
August 6, 2010
First Posted
August 10, 2010
Study Start
January 1, 2010
Primary Completion
April 1, 2016
Study Completion
April 1, 2016
Last Updated
May 18, 2017
Record last verified: 2017-05